BSEM
BioStem Technologies, Inc.
Biotechnology · Healthcare · United States
3.21
close · 2026-08-14
value
95
cheaper than peers95
quality
26
stronger fundamentals26
ranked against
Biotechnology (commercial)
value
quality
109 peerswide variation
Value inputs
| measure | company | vs peers |
| price to sales | 1.52× | 96 |
| price to book | 1.71× | 85 |
| forward P/E | 11.07× | 78 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| debt to equity | 10.3% | 64 |
| return on equity | -48.6% | 41 |
| operating margin | -144.8% | 41 |
| revenue growth | -61.6% | 13 |
4 of 4 measures available
Facts
| market cap | $57M |
| free cash flow | $19.2M |
| employees | 73 |
| first trade | 2015-03-17 |
| next earnings | 2026-08-12 |
| fundamentals updated | 2026-08-14 |